Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19
Analysis discusses the limitations of COVID-19 research and calls for greater coordination among trialists, meta-analysts, and other stakeholders in producing comparative evidence and ensuring its rapid translation into trustworthy guidance.
Source:
British Medical Journal